Washington, Jan 17 (ANI/Business Wire India): Executives from biotechnology and pharmaceutical companies in North America, Europe and the Asia Pacific region will meet to explore business opportunities at the fifth annual BIO-Asia Partnering Conference.
Hosted by the Biotechnology Industry Organization (BIO), the customised partnering forum will take place from January 28 to 29 in Tokyo, Japan.
Two well-known and respected industry leaders will present luncheon keynote speeches at the event.
Toshinari Tamura, Ph.D., representative director, executive vice president and chief science officer of Astellas Pharma Inc., will deliver the luncheon keynote on January 28. James C. Mullen, president and chief executive officer of Biogen Idec, Inc. will deliver the luncheon keynote on January 29.
Thought provoking panel sessions add depth to the program, with sessions including: Trends in M and A and Partnering; When Borders Break Down: The New Generation of Asian Biotechnology Industry; Examining the Different Regulatory Frameworks - Japan, US and Europe and Asian Capital Formation Trends - How Not to Get Lost in Translation.
BIO-Asia is an exclusive partnering forum that brings together Asian-Pacific, North American and European biotechnology and pharmaceutical companies interested in research collaborations and licensing agreements.
The event features private, pre-arranged one-on-one meetings between senior-level executives and provides a number of ways to explore a range of exceptional international partnering and licensing opportunities.
Over the course of two days, BIO-Asia is expected to host more than 1,500 private meetings and provide countless formal and informal networking opportunities.
BIO-Asia 2007 attracted 500 professionals from more than 270 companies and 25 countries around the world.
With over 600 life science executives expected at BIO-Asia 2008, attendance is projected to break records for the fifth year in a row.
BIO-Asia is co-hosted by Mitsubishi UFJ Securities, Mitsubishi UFJ Capital, Montgomery and Co., and BioCentury Publications with support from Japan Bioindustry Association (JBA), Bioindustry Association of Korea (BAK), Association of Biotechnology Led Enterprises (ABLE), AusBiotech, and BIOTECanada.